AWM
PFE icon

Arbor Wealth Management’s Pfizer PFE Stock Holding History

Arbor Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$488K Sell
8,258
-1,435
-15% -$71.1K 0.11% 35
2021
Q3 		$417K Buy
9,693
+179
+2% +$7.93K 0.1% 34
2021
Q2 		$373K Sell
9,514
-374
-4% -$14.5K 0.09% 33
2021
Q1 		$358K Buy
9,888
+400
+4% +$14.2K 0.11% 31
2020
Q4 		$349K Sell
9,488
-4,056
-30% -$149K 0.13% 35
2020
Q3 		$472K Sell
13,544
-1,558
-10% -$54.6K 0.19% 31
2020
Q2 		$469K Sell
15,102
-1,581
-9% -$53.7K 0.22% 31
2020
Q1 		$517K Sell
16,683
-675
-4% -$23K 0.33% 27
2019
Q4 		$645K Buy
+17,358
New +$618K 0.27% 44
2019
Q3 		– Sell
-8,404
Closed -$345K – 156
2019
Q2 		$345K Sell
8,404
-50
-0.6% -$1.99K 0.19% 47
2019
Q1 		$341K Buy
8,454
+7,400
+702% +$296K 0.21% 50
2018
Q4 		$44K Sell
1,054
-46,945
-98% -$1.95M 0.04% 79
2018
Q3 		$2.01M Buy
47,999
+440
+0.9% +$16.9K 1.58% 25
2018
Q2 		$1.85M Sell
47,559
-11,482
-19% -$392K 1.44% 29
2018
Q1 		$2.01M Sell
59,041
-927
-2% -$31.9K 1.71% 26
2017
Q4 		$2.06M Buy
59,968
+3,746
+7% +$128K 1.57% 29
2017
Q3 		$1.89M Sell
56,222
-129
-0.2% -$4.15K 1.61% 29
2017
Q2 		$1.78M Sell
56,351
-800
-1% -$25.2K 1.68% 28
2017
Q1 		$1.79M Buy
57,151
+7,886
+16% +$249K 1.57% 29
2016
Q4 		$1.53K Buy
49,265
+2,917
+6% +$89.1K 1.19% 30
2016
Q3 		$1.44M Buy
46,348
+8,028
+21% +$268K 1.23% 30
2016
Q2 		$1.36M Sell
38,320
-58
-0.2% -$1.85K 1.28% 30
2016
Q1 		$1.22M Buy
38,378
+12,855
+50% +$367K 1.26% 27
2015
Q4 		$694K Buy
+25,523
New +$803K 0.76% 37

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Arbor Wealth Management's PFE Position: Q4 2021 in Review

Arbor Wealth Management reduced its Pfizer (PFE) stake by 15% in Q4 2021, selling an estimated $71.1K and leaving 8,258 shares worth $488K. The position accounts for 0.11% of the portfolio, ranked #35.

Arbor Wealth Management first reported a position in PFE in Q4 2015 and has held it in 24 quarters since. The position peaked at $2.06M in Q4 2017. 3,263 funds tracked by Wall St. Rank hold PFE as of Q4 2021.

  • Arbor Wealth Management held 8,258 shares of Pfizer worth $488K as of Q4 2021.
  • Arbor Wealth Management sold 1,435 Pfizer shares in Q4 2021, an estimated $71.1K.
  • Pfizer made up 0.11% of Arbor Wealth Management's portfolio in Q4 2021, its #35 holding.
  • Arbor Wealth Management first reported a position in Pfizer in Q4 2015 and has held it in 24 quarters since.
  • Arbor Wealth Management's Pfizer position peaked at $2.06M in Q4 2017.
  • 3,263 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.

Based on Arbor Wealth Management's 13F filing for Q4 2021, filed 25 Jan 2022.